A new study reveals the use of beta blockers does not reduce the risk of colorectal cancer, according to the study's abstract.
The study, "Beta blocker use and colorectal cancer risk," was published online May 14 in the journal Cancer.
The research team was led by Michael Hoffmeister of the German Cancer Research Center in Heidelberg, according to a HealthDay News report. The team compared beta blocker use by 1,762 colorectal cancer patients to 1,708 cancer-free people.
Based on the study, the study authors found no link between use of the blood pressure medication and a reduction in risk of colorectal cancer.
They did note a "positive association of long-term beta blocker use and risk of stage IV colorectal cancer," and said this increased risk should be further evaluated.
Related Articles on Colorectal Cancer:
AGA Members Provide Nearly 300 Free Colonoscopies During Colorectal Cancer Awareness Month
6 Legislative and Regulatory Changes Affecting the Ambulatory Surgery Center Industry
Patients Over 50 Give Three Reasons for Avoiding Colorectal Cancer Screenings